In addition, our results showed that other diabetic profiles such as FBG, Insulin, and HOMA-IR and biochemical and hematological parameters such as platelet count, TLC, PT, and AST also failed to segregate NASH and NASH-HCC patients [8]. The gene discussed is INS; the disease is hepatocellular carcinoma.